Journal article
Clinical and Demographic Factors Associated with Antipyretic Use in Gram-Negative Severe Sepsis and Septic Shock
The Annals of pharmacotherapy, Vol.45(10), pp.1207-1216
10/2011
DOI: 10.1345/aph.1Q319
PMCID: PMC3517906
PMID: 21934034
Abstract
Background: Antipyretic therapy is commonly prescribed for patients with Infection, but studies of its impact on clinical outcomes have yielded mixed results. No data exist to characterize the use of antipyretic medications in patients with severe sepsis or septic shock. Objective: To identify clinical and demographic factors associated with antipyretic medication administration in severe sepsis and septic shock. Methods: This single-center, retrospective, cohort study assessed febrile patients [temperature ≥38.3°C) with gram-negative severe sepsis or septic shock at an 1111-bed academic medical center between January 2002 and February 2008, Patients were excluded if they had liver disease, acute brain injury, or allergy to acetaminophen. Generalized estimating equations were used to estimate the effect of clinical factors on treatment of patients with antipyretic medications, Results: Although 76% of patients in this febrile cohort (n = 241) were prescribed an antipyretic agent, only 42% received antipyretic therapy; 95% of the doses were acetaminophen. Variables associated with antipyretic treatment were maximum body temperature (OR 2.11, 95% CI 1.53 to 2.89), time after sepsis diagnosis (OR 0.88, 95% CI 0.82 to 0.95), surgery during hospitalization (OR 0.49, 95% CI 0.31 to 0.80), death within 36 hours (OR 0.35, 95% CI 0.15 to 0.85). and mechanical ventilation (OR 0.58, 95% CI 0.34 to 0.98). Severity of illness factors, demographic factors, and patient treatment location did not predict who would receive antipyretic therapy. Conclusions: Most febrile episodes in patients with gram-negative severe sepsis or septic shock were not treated with antipyretic medications. Further studies are needed to demonstrate the effect of antipyretics on clinically relevant outcomes in severe sepsis and septic shock.
Details
- Title: Subtitle
- Clinical and Demographic Factors Associated with Antipyretic Use in Gram-Negative Severe Sepsis and Septic Shock
- Creators
- Nicholas M Mohr - Division of Critical Care, Department of Anesthesia; Department of Emergency Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, lABrian M Fuller - Division of Critical Care, Department of Anesthesiology; Assistant Professor, Division of Emergency Medicine, School of Medicine, Washington University, St. Louis, MOLee P Skrupky - Department of Pharmacy, Barnes-Jewish Hospital, St. LouisHawnwan Moy - Division of Emergency Medicine, School of Medicine, Washington UniversityRobert Alunday - Division of Emergency Medicine, School of Medicine, Washington UniversityScott T Micek - Department of Pharmacy, Barnes-Jewish HospitalRichard E Fagley - Department of Anesthesiology and Pain Medicine, School of Medicine, University of Washington, Seattle
- Resource Type
- Journal article
- Publication Details
- The Annals of pharmacotherapy, Vol.45(10), pp.1207-1216
- DOI
- 10.1345/aph.1Q319
- PMID
- 21934034
- PMCID
- PMC3517906
- NLM abbreviation
- Ann Pharmacother
- ISSN
- 1060-0280
- eISSN
- 1542-6270
- Language
- English
- Date published
- 10/2011
- Academic Unit
- Epidemiology; Emergency Medicine; Anesthesia; Injury Prevention Research Center
- Record Identifier
- 9984025275402771
Metrics
19 Record Views